Dr Michelle Maritz is a research scientist with extensive research experience in medical biochemistry, cancer research and HIV immunology.
She joined the Bionanoengineering group, lead by Professor Benjmain Thierry at UniSA, Future Industries Institute (FII) in 2018, as a Research Associate. She completed her undergrad and post graduate degree in Medical Biochemistry from the University of Cape Town (UCT), South Africa. She received her PhD from the Children Cancer Institute, UNSW, Australia, where she investigated the functional and molecular consequences of ablating the enzyme telomerase, which underpins the unlimited replicative potential (cellular immortality) of cancer cells. She then took up a post doctoral position... Read more
About me
Dr Michelle Maritz is a research scientist with extensive research experience in medical biochemistry, cancer research and HIV immunology.
She joined the Bionanoengineering group, lead by Professor Benjmain Thierry at UniSA, Future Industries Institute (FII) in 2018, as a Research Associate. She completed her undergrad and post graduate degree in Medical Biochemistry from the University of Cape Town (UCT), South Africa. She received her PhD from the Children Cancer Institute, UNSW, Australia, where she investigated the functional and molecular consequences of ablating the enzyme telomerase, which underpins the unlimited replicative potential (cellular immortality) of cancer cells. She then took up a post doctoral position at the University of Cape in HIV immunology and cervical explant models. Her current research work at UniSA focusses on the development of advanced preclinical in vitro models and new approaches for cancer immunotherapy and she co-supervisors a number of PhD students within the group.
Research
Research since 2008 is shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2019 |
58
|
| 2019 |
Open access
2
3
|
| 2016 |
10
8
3
|
| Year | Output |
|---|---|
| 2019 |
|
| 2019 |
58
|
| 2019 |
Open access
|
| 2019 |
Open access
2
3
|
| 2016 |
10
8
3
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Boston Children's Cancer and Blood Disorders Center | UNITED STATES |
| Children's Cancer Institute Australia | AUSTRALIA |
| Children's Medical Research Institute | AUSTRALIA |
| Dana-Farber Cancer Institute | UNITED STATES |
| Royal Adelaide Hospital | AUSTRALIA |
| University of Bologna | ITALY |
| University of Cape Town | SOUTH AFRICA |
| University of Houston | UNITED STATES |
| University of New South Wales | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Development of nanomedicines for the radiosensitization of proton beam therapy | Current |
| In vivo manufacturing of CAR-T cells using targeted non-viral nanocarriers | Current |
| Next generation bioengineered in vitro tumour models | Current |
